Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › vancomycin

vancomycin

13 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of vancomycin

62 trials tracked of vancomycin: 35 in phase 3 or 4 and 14 with published results. The most-cited published study has 106 citations.

62Trials tracked
35Phase 3 & 4
0Recruiting
14With published results
Phase distribution
Phase 4 13 Phase 3 22 Phase 2 15 Phase 1 3 Other / NA 9
  1. Phase 3 Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections Completed · 106 cited
  2. Phase 3 Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections Completed · 104 cited
  3. Phase 3 Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005) Completed · 72 cited
  4. Phase 3 A Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-006) Completed · 71 cited
  5. Phase 3 Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea Completed · 66 cited
  6. Phase 3 Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea Completed · 66 cited
Show 44 more trials
  1. Phase 3 Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1 Completed · 49 cited
  2. Phase 3 Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2 Completed · 38 cited
  3. Phase 3 Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection Completed · 34 cited
  4. Phase 4 Study to Assess Inhibition of Spore Production in Patients With C. Difficile Infections: Fidaxomicin Versus Vancomycin Completed · 32 cited
  5. Phase 3 Regional Prophylactic Vancomycin With Restricted Tourniquet Time in Primary Total Knee Replacement Completed · 32 cited
  6. Phase 4 A Comparison of Fidaxomicin and Vancomycin in Patients With CDI Receiving Antibiotics for Concurrent Infections Completed · 16 cited
  7. Phase 4 Impact of Oral Antibiotic Treatment on C. Difficile Completed · 15 cited
  8. Phase 3 Topical Vancomycin for Neurosurgery Wound Prophylaxis Completed · 9 cited
  9. Phase 4 A Randomized Trial of Preoperative Prophylactic Antibiotics Prior to Kidney Stone Surgery (Percutaneous Nephrolithotomy [PCNL]) Completed
  10. Phase 4 Preoperative Antibiotics for Carpal Tunnel Release Surgery Completed
  11. Phase 4 Responses to Rabies Vaccine in Adults With or Without Antibiotics Completed
  12. Phase 4 Screening to Prophylax Against Clostridium Difficile Infection - Completed
  13. Phase 4 Acute Application of Antibiotic Powder in Open Fracture Wounds Completed
  14. Phase 4 Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA Completed
  15. Phase 4 Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA) Completed
  16. Phase 4 Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections Completed
  17. Phase 4 Effect of Probiotic Supplementation on Endothelial Function Completed
  18. Phase 4 Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA) Completed
  19. Phase 3 Regional Prophylactic Vancomycin in Revision Total Knee Replacement Completed
  20. Phase 3 A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) Completed
  21. Phase 3 Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA Completed
  22. Phase 3 Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus Completed
  23. Phase 3 Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018) Completed
  24. Phase 3 PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) Completed
  25. Phase 3 Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus Completed
  26. Phase 3 China Registration Study in Patients With Skin Infections Completed
  27. Phase 3 Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus Completed
  28. Phase 3 Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus Completed
  29. Phase 3 Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections Completed
  30. Phase 2 Investigation of the Gut Microbiota in Regulating Nutrient Absorption in Humans Completed
  31. Phase 2 Topical Antibiotics in Chronic Rhinosinusitis Completed
  32. Phase 2 ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection Completed
  33. Phase 2 The Effect of an Antibiotic on the Production of Uremic Toxins by the Gut Microbiome Completed
  34. Phase 2 A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections Completed
  35. Phase 2 Study of CB-183,315 in Participants With Clostridium Difficile Infection Completed
  36. Phase 2 Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI) Completed
  37. Phase 2 DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia Completed
  38. Phase 2 Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection Completed
  39. Phase 2 Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease Completed
  40. Phase 2 PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN Completed
  41. Phase 2 TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection Completed
  42. Phase 2 Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci Completed
  43. Phase 2 Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection Completed
  44. Phase 2 Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease Completed

Showing the 50 most-cited and recently-updated of 62 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Retrospective cohort study examines MRSA prevalence and resistance patterns in nosocomial bloodstream infections among 96 patients in central China
Primary Care & Family Medicine Cohort
Retrospective cohort study examines MRSA prevalence and resistance patterns in nosocomial bloodstream infections among 96 patients in central China Are hospital infections getting harder to treat, or is the data stable?
This retrospective cohort study analyzed 96 Staphylococcus aureus isolates from patients with nosocomial bloodstream infections at a tertiar…
Hospital bloodstream infections from tough MRSA bacteria stayed stable in frequency, but one patient's germ was resistant to the last-resort…
Frontiers Apr 14, 2026